Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma (Q43824354)
Jump to navigation
Jump to search
scientific article published in November 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma |
scientific article published in November 2001 |
Statements
1 reference
Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma (English)
1 reference
J Bonneterre
1 reference
A Buzdar
1 reference
J M Nabholtz
1 reference
J F Robertson
1 reference
B Thürlimann
1 reference
M von Euler
1 reference
T Sahmoud
1 reference
A Webster
1 reference
M Steinberg
1 reference
Arimidex Writing Committee
1 reference
Investigators Committee Members
1 reference
1 November 2001
1 reference
Identifiers
1 reference